COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)
Clinical trial NCT04384588 · UNKNOWN
Trial details
- NCT number
- NCT04384588
- Sponsor
- Fundacion Arturo Lopez Perez
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-07
- Primary completion
- 2021-04-06
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.